Long intergenic non-protein coding RNA 1262 (LINC01262)

Long intergenic non-protein coding RNA 1262 (LINC01262) is a member of the long intergenic non-coding RNA (lincRNA) family, which consists of RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and typically do not code for proteins themselves. Like other lincRNAs, LINC01262 is thought to play roles in gene regulation through mechanisms such as chromatin remodeling, modulation of transcription, and stabilization of RNA. Recent studies have identified LINC01262 as differentially expressed in acute myeloid leukemia (AML), highlighting its potential as a biomarker for AML risk and prognosis; however, its molecular mechanisms and specific partnering molecules remain largely uncharacterized. Importantly, while lincRNAs can influence disease processes (notably in cancer), they are not classical therapeutic targets such as receptors, enzymes, or transporters, and there are no known drugs targeting LINC01262 directly.

Other names

TCONS_l2_00021807RP11-462G22.1LINC01262